Imago BioSciences, Inc. operates as a clinical-stage biopharmaceutical company that develops novel anti-cancer therapeutics. It translates science of genetics and epigenetics enzymes into novel medicines for treating myeloid diseases that pose challenges to patients, families, and physicians. The company also translates insights into transformative therapies that alter the history of disease allowing patients to live longer and disease-free lives. Imago BioSciences was founded by Hugh Young Rienhoff, Jr., Laura G. Eichorn and Jennifer Peppe on March 29, 2012 and is headquartered in Redwood City, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Imago BioSciences Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Imago BioSciences Inc market cap is $1.22B.
What is the 52-week high for Imago BioSciences Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Imago BioSciences Inc 52 week high is $36.09 as of September 06, 2025.
What is the 52-week low for Imago BioSciences Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Imago BioSciences Inc 52 week low is $11.56 as of September 06, 2025.
What was Imago BioSciences Inc stock price yesterday?
Imago BioSciences Inc stock price yesterday was $36.01.
What is the PE ratio of Imago BioSciences Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Imago BioSciences Inc’s P/E ratio is -19.67.
What is the Price-to-Book ratio of Imago BioSciences Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Imago BioSciences Inc P/B ratio is 7.0544.
What is the 50-day moving average of Imago BioSciences Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Imago BioSciences Inc 50-day moving average is $30.21.